Clinical Trial Update: Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD [Phase 2]

View source ↗

Summary

Phase 2 study of HUCNS-SC subretinal transplantation for geographic atrophy in age-related macular degeneration has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• HUCNS-SC Subretinal Transplantation (human umbilical cord neural stem cells)

Snippet

Sponsor: StemCells, Inc. | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: TERMINATED